Navigation Links
$3 Million Requested by UNFPA to Help Women and Girls Displaced by Myanmar Cyclone
Date:5/9/2008

UNITED NATIONS, May 9 /PRNewswire-USNewswire/ -- UNFPA, the United Nations Population Fund, is appealing for $3 million to address the urgent humanitarian concerns of cyclone-affected populations, particularly women and girls, in Myanmar's Ayeyarwady and Yangon regions.

The amount is being sought as part of a joint flash appeal to be launched by the United Nations today. Tens of thousands of pregnant women made homeless by the cyclone urgently need lifesaving assistance. UNFPA is working with humanitarian partners to mobilize emergency reproductive health supplies, including safe delivery kits, for those affected.

Disasters like Cyclone Nargis put expectant mothers and their babies at special risk because of the sudden loss of medical support, compounded by trauma, malnutrition and disease. Among the estimated 1.5 million people severely affected by the storm, one in five women of childbearing age is likely to be pregnant; around 15 per cent of them will suffer from complications during labour.

Teams from United Nations and non-governmental agencies are assessing the needs for food, water, sanitation, shelter and health among the displaced. As part of the coordinated international response, UNFPA will send supplies to make deliveries safer. These include individual kits containing a clean razor blade, a string for cutting and tying the umbilical cord, a plastic sheet, a bar of soap, and a blanket to keep the newborn warm. This would save infants and prevent life-threatening post-delivery infections in mothers who cannot reach a medical facility.

Medicines and equipment will also be sent to help health workers take care of women with complicated pregnancies. These include intravenous drip sets, antibiotics, painkillers, syringes, sterile gloves and small sterilizing machines.

In the emergency projects outlined in today's flash appeal, UNFPA will work with key United Nations organizations and local and international
'/>"/>

SOURCE United Nations Population Fund
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2008)...ay 11 /PRNewswire/ -- The winners of today,s Susan...ollows:, 1st Place Overall Winners Male: ...le: Kelly Knickelbein, Pittsburgh, Pa., 19:19, 2... 16:02 Female: Anna Beck, Washington, Pa., 1...ie Ban, Pittsburgh, Pa., 16:13 Female: Jessi...
(Date:5/11/2008)...norCare Facilities, Caregivers Call for Better Car...swire-USNewswire/ -- Families visiting their,loved...in sixteen states,across the nation this Mother,s ...from quality care advocates. The effort asks famil...Director David Rubenstein to demand better,care. I...
(Date:5/10/2008)...ay 10 /PRNewswire/ -- Children,s Hospital of Pitts...ts new state-of-the-art hospital,campus., (Photo:...A001 ), When the new Children,s Hospital opens i... care nationwide. The new hospital building will,s...ment project that is,situated on a 10-acre campus....
(Date:5/9/2008)...cation Indicated for Maintenance Treatment for ADH...Eli Lilly and Company,(NYSE: LLY ) announced toda...ion (FDA) has approved Strattera(R) (atomoxetine H.../Hyperactivity Disorder (ADHD) in,children and ado...uptake,inhibitor, is the first FDA-approved non-st...
Breaking Medicine News(10 mins):Health News:16th Annual Komen Pittsburgh Race for the Cure(R) Winners Announced 2Health News:Advocates Make Mother's Day Push for Quality Care 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 3Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 4Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 3Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 4Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 5Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 6
...’s or KFC restaurants, across the world, have vary...an the levels of the same // food elsewhere. Accor...ew England Journal of Medicine, the researchers an...d's chicken nuggets, KFC hot wings, french fries f...
...hich is in its infancy demands a lot of funding to...ouncil of Medical Research (ICMR).// Delivering t...em cell research in India', Ganguly said there was...for such research. 'There is a huge scope but wha...
...un while men buy for comfort. Well, that is about ...healthy and comfortable// options this spring. The...s, flat shoes and wedge heels. Dr. Brodsky, orth...edical staff at Baylor University Medical Center a...
...ence inflammation. According to a German clinical ... University of Bonn, it was found that high doses ...ory molecules and appear to boost the anti-inflamm...e published in the American Journal of Clinical Nu...
Other Medicine News:Health News:High Dose Of Vitamin D3 A Boon for Patients Suffering From Heart Failure 2
(Date:5/8/2008)...he Cancer Research Alliance, an,organization compr...asking,303 million Americans to exercise their pow...fforts this Mother,s Day through Father,s Day., T..." has two key goals:,to activate Americans everywh...g together to exercise their collective power over...
(Date:5/8/2008)...FirstCall/ -- Alpharma Inc. (NYSE: ALO ),a globa...d results from,clinical trials that showed ALO-01 ...th sequestered naltrexone hydrochloride) capsules,...ng abuse liability,alongside a promising safety an...esented at the 27th Annual Scientific Session of t...
(Date:5/8/2008)...wire-FirstCall/ -- VION PHARMACEUTICALS,INC. (Nas...tigator-sponsored,Phase I/II clinical trial of its...in combination with cytarabine in elderly patients...mia (AML) and high-risk,myelodysplastic syndromes ...ction of Ellen K. Ritchie, M.D. at The Weill-Corne...
(Date:5/8/2008)... Center Investigators to Assess BSI-201 ..., BRISBANE, Calif., May 8 /- BiPar S...se 2 clinical trial programs for its lead,product,...or clinical trial,of BSI-201 that BiPar has launch...als in breast and brain cancer., The company is e...
Breaking Medicine Technology:World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Chemizon Announces Research Collaboration Expansion With Takeda 2456 1Chemizon Announces Research Collaboration Expansion With Takeda 2456 2Assay Designs 28TM 29 Announces Additions to the Leadership Team 955 1Assay Designs 28TM 29 Announces Additions to the Leadership Team 955 2Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2452 1Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2452 2Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2452 3Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2452 4Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2452 5Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2452 6Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2452 7Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2452 8Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 1Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 2Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 3Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 4
... Evaluable Patients Receiving Combination of,Bavit...,Tumor Response or Stable Disease - , - 75% of ... Gemcitabine , ,Achieved Objective Tumor...Patients Receiving Combination of Bavituximab Plus...ive Tumor Response - , - Trial Results Suppo...
...l Drug Being Pursued for the Treatment of Ischemic...re-FirstCall/ --,Neurobiological Technologies, Inc...alysis of data from prior clinical trials of,ancro...,investigational drug, Viprinex (ancrod), for the ...ual European Stroke Congress in,Glasgow, Scotland ...
Other Medicine Technology:Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 2Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 3Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 4Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 5Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 2Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 3Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 4
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: